Skip to Main content Skip to Navigation
Journal articles

Is COVID-19 a New Hematologic Disease?

Abstract : SARS-CoV-2 viruses are positive single-stranded RNA viruses, whose infection can be asymptomatic or lead to the coronavirus disease 2019 (Covid-19). Covid-19 is a respiratory infection with a significant impact on the hematopoietic system and hemostasis leading to several cardiovascular complications. Hematologic consequences of this new infection allowed medical community to start new treatment approaches concerning infection going from targeted anti-inflammatory drugs to anticoagulation or stem cell therapies. A better understanding of Covid-19 pathophysiology, in particular hematological disorders, will help to choose appropriate treatment strategies.
Complete list of metadata

Cited literature [53 references]  Display  Hide  Download
Contributor : Myriam Bodescot Connect in order to contact the contributor
Submitted on : Monday, May 18, 2020 - 11:57:09 AM
Last modification on : Thursday, April 7, 2022 - 1:58:34 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document




Benjamin Debuc, David M Smadja. Is COVID-19 a New Hematologic Disease?. Stem Cell Reviews and Reports, Humana Press, 2020, Epub ahead of print. ⟨10.1007/s12015-020-09987-4⟩. ⟨inserm-02611228⟩



Record views